- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,855,533
- Total 13F shares
- 81,025,132
- Share change
- +2,614,259
- Total reported value
- $3,295,908,701
- Put/Call ratio
- 28%
- Price per share
- $40.67
- Number of holders
- 201
- Value change
- +$98,098,293
- Number of buys
- 113
- Number of sells
- 91
Quarterly Holders Quick Answers
What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69366J200:
Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
9,583,168
|
$464,208,657 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
7,587,782
|
$367,552,160 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.8%
|
7,093,298
|
$343,599,355 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.7%
|
6,997,691
|
$338,968,152 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.8%
|
6,269,990
|
$303,718,313 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
4.3%
|
3,445,798
|
$166,914,445 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4%
|
3,196,304
|
$154,839,364 | — | 31 Mar 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.6%
|
2,924,000
|
$141,638,560 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
2,905,133
|
$140,724,643 | — | 31 Mar 2023 | |
| Camber Capital Management LP |
13F
|
Company |
3.1%
|
2,500,000
|
$121,100,000 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.3%
|
1,847,000
|
$89,468,680 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
1,717,765
|
$83,210,000 | — | 31 Mar 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2%
|
1,643,150
|
$79,594,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,385,410
|
$67,109,277 | — | 31 Mar 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.5%
|
1,231,082
|
$59,634,000 | — | 31 Mar 2023 | |
| Blackstone Inc. |
13F
|
Company |
1.4%
|
1,095,290
|
$53,055,848 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.2%
|
965,306
|
$46,759,437 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
868,453
|
$42,068,000 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.89%
|
722,873
|
$35,015,968 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.87%
|
705,518
|
$34,175,292 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
656,863
|
$31,818,444 | — | 31 Mar 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.75%
|
605,120
|
$29,312,000 | — | 31 Mar 2023 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.74%
|
601,083
|
$29,116,000 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.71%
|
570,451
|
$27,632,646 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
558,309
|
$27,044,488 | — | 31 Mar 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.64%
|
517,095
|
$25,048,082 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.63%
|
509,532
|
$24,681,730 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
452,682
|
$21,927,916 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
446,364
|
$21,621,873 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.52%
|
421,393
|
$20,412,277 | — | 31 Mar 2023 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.42%
|
339,426
|
$16,441,795 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.41%
|
328,642
|
$15,919,418 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.4%
|
324,900
|
$15,738,156 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.34%
|
277,652
|
$12,379,275 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.31%
|
249,074
|
$12,065,144 | — | 31 Mar 2023 | |
| Redwood Investments, LLC |
13F
|
Company |
0.3%
|
242,639
|
$11,753,433 | — | 31 Mar 2023 | |
| Holocene Advisors, LP |
13F
|
Company |
0.3%
|
242,623
|
$11,752,658 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.3%
|
239,916
|
$11,621,528 | — | 31 Mar 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.28%
|
226,566
|
$10,974,857 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
225,890
|
$10,942,111 | — | 31 Mar 2023 | |
| Stuart Walter Peltz |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
399,365
mixed-class rows
|
$10,876,127 | — | 31 Jan 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
209,252
|
$10,136,000 | — | 31 Mar 2023 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.24%
|
192,000
|
$9,300,000 | — | 31 Mar 2023 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.23%
|
189,973
|
$9,202,000 | — | 31 Mar 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.22%
|
178,000
|
$8,622,320 | — | 31 Mar 2023 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.21%
|
170,084
|
$8,238,869 | — | 31 Mar 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.2%
|
159,100
|
$7,706,804 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.19%
|
157,443
|
$7,626,539 | — | 31 Mar 2023 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.19%
|
157,120
|
$7,610,892 | — | 31 Mar 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.19%
|
150,000
|
$7,266,000 | — | 31 Mar 2023 |
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2023
As of 30 Jun 2023,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,025,132 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, and Camber Capital Management LP.
This page lists
202
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
198
Q2 2023 holders
201
Holder diff
3
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.